SXC 2023
SXC 2023 is a prodrug of N-acetyl-L-cysteine designed for research into CNS and neurocognitive disorders. Its application in preclinical studies focuses on addressing conditions involving glutamatergic dysfunction and oxidative stress, such as psychiatric disorders, in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1695562-36-7
Product Name Alternative
SXC 2023, SXC2023, SXC-2023, (S) -2-acetamido-3- (4-methylbenzoylthio) propanoic acid, 2-acetamido-3- (4-methylbenzoylthio) propanoic acid
Purity
99.65% (May vary between batches)
Solubility
DMSO:55 mg/mL (195.5 mM)
Smiles
C (SC[C@H] (NC (C) =O) C (O) =O) (=O) C1=CC=C (C) C=C1
Molecular Formula
C13H15NO4S
Molecular Weight
281.33
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS668979-01 0.1 mg
Monoclonal Antibody to hCD19 (Clone: CB19) FITC Conjugated
Sign In for Pricing
View Details MBS668979-02 5x 0.1 mg
Monoclonal Antibody to hCD19 (Clone: CB19) FITC Conjugated
Sign In for Pricing
View Details HHC67783-01 50 mg
4-[ (tert-Butyldimethylsilyl) oxy]naphthalene-2-carboxylic acid
Sign In for Pricing
View Details